SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

WEEDCOIN is trending following a retail frenzy fueled by discussions around recent federal cannabis reclassification, seen as a significant catalyst for the sector. The community highlights WEEDCOIN as the primary beneficiary and a leading cultural play within the Solana ecosystem, positioning it as an on-chain alternative to traditional pharmaceutical models. Sentiment emphasizes its potential for substantial growth as the "Green Wave" gains momentum.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

The SPDR Dow Jones Industrial Average ETF ($DIA) is actively debated as strong US economic data, including robust GDP and softening inflation, fuels optimism for a year-end rally. However, community sentiment is split, with many cautioning against "inorganic" holiday trading and potential global liquidity shifts, while others see DIA as an old economy barometer confirming broader market strength or weakness.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP Token is actively trending as discussions focus on its real-world utility through Flexa's expanding merchant network, enabling crypto payments at major retailers like Chipotle and Nordstrom. This visibility fuels optimism among long-term holders for future adoption and significant price recovery, contrasting with skepticism from those wary of past volatility and downward price trends. The community remains divided, debating whether current momentum signals a sustained uptrend or another fleeting pump.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is gaining attention for its expanding anticoagulation pipeline, highlighted by recent acquisitions and significant progress on its lead candidate, tecarfarin, including manufacturing readiness and a collaboration with Abbott. This "quiet expansion" is sparking community interest, with many anticipating a breakout given its low float and regulatory designations. However, skepticism persists among some regarding the company's financial stability and potential dilution.

TotalEnergies SE is a global integrated energy company, which engages in the production of oil and biofuels, natural gas and green gases, renewables and electricity. It operates through the following business segments: Exploration & Production, Integrated LNG, Integrated Power, Refining & Chemicals, and Marketing & Services. The Exploration & Production segment encompasses oil and natural gas exploration and production activities. The Integrated LNG segment includes the integrated gas chain (including upstream and midstream LNG activities) as well as biogas, hydrogen and gas trading activities. The Integrated Power segment involves in the generation, storage, electricity trading and B2B-B2C distribution of gas and electricity. The Refining & Chemicals segment engages in the activities of refining, petrochemicals and specialty chemicals. This segment also includes the activities of oil supply, trading and marine shipping. The Marketing & Services segment includes the global activities of supply and marketing in the field of petroleum products. The company was founded on March 28, 1924 and is headquartered in Courbevoie, France.

TotalEnergies SE

Total Energies

TotalEnergies is trending as it expands its clean energy footprint with significant long-term deals, including powering Google's data centers, and actively pursues high-potential deepwater oil and gas exploration projects. The community is discussing its compelling dividend yield and strategic portfolio transformation, alongside its potential consideration for a New York listing to enhance valuation.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc Health is trending as discussions center on its strategic positioning to capitalize on the multi-billion dollar Rural Health Transformation Program and its new TytoCare integration, aiming to expand virtual care in underserved areas. Community sentiment is sharply divided, with many anticipating a significant long-term rebound driven by healthcare reform and AI innovation, while others express deep frustration over past financial performance, leadership decisions, and persistent stock underperformance. The conversation reflects a strong divergence between high conviction in a future turnaround and calls for greater accountability from management.

Parker-Hannifin Corp. engages in the manufacture of motion and control technologies and systems. It operates through the Diversified Industrial and Aerospace Systems segments. The Diversified Industrial segment sells products to both original equipment manufacturers and distributors who serve the replacement markets in manufacturing, packaging, processing, transportation, mobile construction, refrigeration and air conditioning, agricultural and military machinery, and equipment industries. The Aerospace Systems segment offers products primarily in the commercial and military aerospace markets to both OEMs and to end users for spares, maintenance, repair, and overhaul. The company was founded by Arthur L. Parker in 1918 and is headquartered in Cleveland, OH.

Parker-Hannifin Corp.

Parker-Hannifin ($PH) is trending following its strategic acquisition of Filtration Group for over $9 billion, a move anticipated to significantly expand its market leadership and boost future earnings. This major corporate development, combined with continued strong performance in its Aerospace Systems segment and its reputation as a "Dividend King," is fueling bullish analyst sentiment and investor discussion, despite some debates around its current valuation.

SPDR Series Trust - State Street SPDR S&P Oil & Gas Exploration & Production ETF

SPDR Oil & Gas Exploration & Production ETF

The oil and gas exploration and production sector, represented by XOP, is fueling vigorous community debate, with many investors actively accumulating on perceived dips amidst discussions of a suppressed physical market and surging global demand from emerging economies and data centers. Despite ongoing geopolitical uncertainties and varied economic forecasts, there's a strong contrarian belief that the sector is building towards a significant long-term breakout into the late 2020s.

Ameriprise Financial, Inc. operates as a holding company. The firm provides financial planning, asset management and insurance services to individuals, businesses and institutions. It operates through the following business segments: Advice & Wealth Management, Asset Management, Retirement & Protection Solutions, and Corporate & Other. The Advice & Wealth Management segment provides financial planning and advice, as well as full-service brokerage and banking services, primarily to retail clients through the company's financial advisors. The Asset Management segment provides investment advice and investment products to retail and institutional clients. It also provides products and services on a global scale through two complementary asset management businesses: Columbia Management and Threadneedle. The Columbia Management business primarily provides U.S. domestic products and services and Threadneedle primarily provides international investment products and services. Its international retail products are primarily provided through third-party financial institutions. The segments retail products include mutual funds and variable product funds underlying insurance and annuity separate accounts. The Retirement & Protection Solutions segment offers a variety of protection products to address the protection and risk management needs of the company's retail clients, including life, DI, and property-casualty insurance. The Corporate & Other segment consists of net investment income on corporate level assets, including excess capital held in the company's subsidiaries and other unallocated equity and other revenues from various investments as well as unallocated corporate expenses. The company was founded by John Tappan in 1894 and is headquartered in Minneapolis, MN.

Ameriprise Financial Inc

Ameriprise Financial is trending amidst robust discussion, notably due to widespread user confusion with a similarly-named crypto token. For the actual NYSE-listed wealth manager, recent strong earnings, consistent growth in assets under management, and strategic advisor team acquisitions are driving positive sentiment. These business developments, coupled with a dividend increase and share repurchase authorization, are fueling community debate over its continued momentum in the financial sector.

ConocoPhillips is an exploration and production company, which engages in the exploration, production, transport, and marketing of crude oil, bitumen, and natural gas. It operates through the following geographical segments: Alaska, Lower 48, Canada, Europe, Middle East, and North Africa, Asia Pacific, and Other International. The Alaska segment explores for, produces, transports and markets crude oil, natural gas and NGLs. The Lower 48 segment consists of operations located in the 48 contiguous U.S. states and the Gulf of Mexico. The Canada segment refers to oil sands development in the Athabasca Region of northeastern Alberta and a liquids-rich unconventional play in western Canada. The Europe, Middle East, and North Africa segment includes operations in the Norwegian sector of the North Sea, the Norwegian Sea, Qatar, Libya, Equatorial Guinea and commercial and terminalling operations in the U.K. The Asia Pacific segment focuses on explorations and product operations in China, Indonesia, Malaysia, and Australia. The Other International segment handles exploration activities in Columbia and Argentina. The company was founded by Isaac Elder Blake on November 25, 1875 and is headquartered in Houston, TX.

Conoco Phillips

ConocoPhillips is a key focus following its Marathon Oil acquisition, which enhances its low-cost U.S. shale portfolio and is projected to deliver over $1 billion in annual synergies. The community is actively discussing COP's strong Q4 earnings beat, substantial shareholder return commitments, and strategic moves in LNG and Arctic exploration. Investors are weighing these developments against volatile oil prices and geopolitical events, highlighting the company's long-term resilience.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Moody Aldrich Partners LLC Buys Shares of 25,884 Ligand Pharmaceuticals Incorporated $LGND

Moody Aldrich Partners LLC bought a new position in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F...

Calamos Advisors LLC Grows Stake in Ligand Pharmaceuticals Incorporated $LGND

Calamos Advisors LLC lifted its position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 69.8% during the 3rd quarter, according to the company in its most recent Form 13F...

Ligand Pharmaceuticals Incorporated $LGND Position Trimmed by Rice Hall James & Associates LLC

Rice Hall James & Associates LLC trimmed its position in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 12.7% in the 3rd quarter, according to its most recent disclosure...

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Consensus Recommendation of "Moderate Buy" by Analysts

Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Get Free Report) have been given a consensus rating of "Moderate Buy" by the seven ratings firms that are presently covering the company...

Ligand Pharmaceuticals (NASDAQ:LGND) Releases FY 2025 Earnings Guidance

Ligand Pharmaceuticals (NASDAQ:LGND) updated its FY 2025 earnings guidance. The company provided EPS guidance of 7.400-7.650 for the period, compared to the consensus estimate of 4.370. The company...

Ligand Pharmaceuticals Incorporated $LGND Stock Holdings Increased by Congress Asset Management Co.

Congress Asset Management Co. raised its holdings in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 3.0% in the third quarter, according to its most recent Form 13F...

Woodstock Corp Sells 9,472 Shares of Ligand Pharmaceuticals Incorporated $LGND

Woodstock Corp lessened its holdings in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 32.1% in the third quarter, according to its most recent 13F filing with the...

FY2026 Earnings Forecast for LGND Issued By Zacks Small Cap

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) - Analysts at Zacks Small Cap upped their FY2026 earnings per share estimates for Ligand Pharmaceuticals in a note issued to investors...

Octavio Espinoza Sells 1,804 Shares of Ligand Pharmaceuticals (NASDAQ:LGND) Stock

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Get Free Report) CFO Octavio Espinoza sold 1,804 shares of the business's stock in a transaction dated Friday, December 12th. The shares were sold...

Ligand Pharmaceuticals (NASDAQ:LGND) CFO Sells $339,711.24 in Stock

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Get Free Report) CFO Octavio Espinoza sold 1,804 shares of the company's stock in a transaction on Friday, December 12th. The shares were sold at an...

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.

LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LGND News

LGNDLigand Pharmaceuticals, Inc. - Ordinary Shares - Class B